Therapeutic plasma exchange normalizes insulin-mediated response in a child with type 1 diabetes and insulin autoimmune syndrome
- 29 March 2017
- journal article
- research article
- Published by Wiley in Pediatric Diabetes
- Vol. 19 (1) , 171-179
Abstract
Insulin autoimmune syndrome (IAS), characterized by glycemic dysregulation and life-threatening hypoglycemia, can occur in patients with type 1 diabetes (T1D). Diagnostic confirmation is complex but important in order to ensure timely initiation of definitive therapy. We aimed to quantitate the degree of immunoglobulin-insulin complex (IIC) formation and its effects on glycemic control in a patient with T1D and IAS compared with T1D and non-T1D controls and before and after therapeutic plasma exchange (TPE). The prospective descriptive study was conducted between June 2015 and December 2015 in a quaternary children's hospital in Brisbane, Australia. Percent Free “Immunoreactive” Insulin (%FII) as assessed by polyethylene glycol precipitation studies and its relationship to plasma glucose and serum insulin concentration. Samples from the patient with T1D and IAS demonstrated lower mean %FII compared to T1D (23.8 ± 2.0 vs 52.0 ± 6.7; P < .0001) and non-T1D (23.8 ± 2.0 vs 102.9 ± 2.7; P < .0001) controls. This was associated with loss of glycemic predictability and frequent severe hypoglycemia. TPE increased %FII (23.8 ± 2.0 before TPE vs 83.6 ± 2.5 after TPE, P < .0001) and reestablished plasma glucose responsiveness to exogenous insulin. IAS should be considered in T1D patients with unexplained glycemic instability and hypoglycemia. The laboratory plays an integral diagnostic role. TPE is an effective method for removing IICs and normalizing insulin-mediated glucose responses.Keywords
This publication has 21 references indexed in Scilit:
- A simplified method to assess affinity of insulin autoantibodiesClinical Immunology, 2010
- The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapyActa Diabetologica, 2010
- Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose controlDiabetes/Metabolism Research and Reviews, 2009
- Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodiesDiabetes Research and Clinical Practice, 2009
- Insulin Binding to Antibodies is a Risk Factor for Inexplicable Severe Hypoglycaemia in Children with Type-1 Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes, 2008
- Paradoxical Elevation of High–Molecular Weight Adiponectin in Acquired Extreme Insulin Resistance Due to Insulin Receptor AntibodiesDiabetes, 2007
- The Interference of Insulin Antibodies in Insulin Immunometric AssaysClinical Chemistry and Laboratory Medicine (CCLM), 2002
- A Novel Micro-assay for Insulin AutoantibodiesJournal of Autoimmunity, 1997
- Prolonged Fasting Hypoglycemia Due to Insulin Antibodies in Patient With Non-Insulin-Dependent Diabetes Mellitus: Effect of Insulin Withdrawal on Insulin-Antibody—Binding KineticsDiabetes Care, 1987
- Circulating insulin-binding antibodiesDiabetologia, 1980